{"SPADE_UN_13455": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_13455", "Peptide Name": "dCATH 12-4 (modified from dCATH 12)", "Source": "Synthetic construct", "Family": "Not found", "Gene": "N/A", "Sequence": "LIKKIYRKWKRW", "Sequence Length": 12, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic form", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram-", "Anti-Gram+"], "Target Organism": "[Ref.32698035] Gram-positive bacteria:S. aureus KCTC 1621 (MIC = 4 μM), S. epidermidis KCTC 1917 (MIC = 4 μM), B. subtilis KCTC 3068 (MIC = 2 μM);Resistant Gram-positive bacteria:MRSA CCARM 3089 (MIC = 16 μM), MRSA CCARM 3090 (MIC = 8 μM), MRSA CCARM 3095 (MIC = 8 μM), VREF ATCC 51559(MIC = 8 μM);Gram-negative bacteria:E. coli KCTC 1682 (MIC = 8 μM), P. aeruginosa KCTC 1637(MIC = 2 μM), S. typhimurium KCTC 1926 (MIC = 2 μM);Resistant Gram-negative bacteria:MDRPAd CCARM 2095 (MIC = 8 μM), MDRPA CCARM 2109 (MIC = 8 μM);Yeast:C. albicans KCTC 7965 (MIC = 8 μM), C. albicans KCTC 7121 (MIC = 4 μM).", "Hemolytic Activity": "[Ref.32698035] HC10 > 256 μM. Note:HC10 is the peptide concentration that caused 10% hemolysis of sheep red blood cells (sRBCs).", "Cytotoxicity": "[Ref.32698035] At the concentration of 1.25, 2.5, 5, 10, 20, 40, 80 μM, the cell survival of dCATH 12-4 against human bone marrow SH-SY5Y cells is 102%, 102%, 100%, 100%, 100%, 91%, 83%.", "Binding Target": "Bacterial DNA", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Among the 12-meric analog AMPs, Trp rich dCATH 12–4 and dCATH 12-5 displayed high helicity in all membrane-mimetic environment with highest α-helical conformation observed (42.8% and 40.4% respectively) in 0.1% LPS", "Formula": "C85H136N24O14", "Mass": 1718.14, "PI": 11.22, "Net Charge": 6, "Hydrophobicity": -1.24, "Half Life": "Mammalian:5.5 hourYeast:3 minE.coli:2 min", "Comments": "dCATH 12-4 demonstrated synergistic actions with various conventional antibiotics against antibiotic resistant pathogens, thus indicating their ability as promising adjuncts to combination therapy.", "Literature": [{"Title": "Antimicrobial and anti-inflammatory activities of short dodecapeptides derived from duck cathelicidin Plausible mechanism of bactericidal action and endotoxin neutralization", "Pubmed ID": "32698035", "Reference": "Eur J Med Chem. 2020 Oct 15;204112580. doi 10.1016/j.ejmech.2020.112580. Epub 2020 Jul 16.", "Author": "Kumar SD, Shin SY", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=32698035"}], "Frequent Amino Acids": "KIR", "Absent Amino Acids": "ACDEFGHMNOPQSTUV", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 6, "Polar Residues": 7, "Positive Residues": 6, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_01054", "Similarity": 1.0, "Sequence": "ILGPVLSLVGSALGGLIKKI"}, {"SPADE_ID": "SPADE_N_01055", "Similarity": 1.0, "Sequence": "ILGPVLGLVSNAIGGLIKKI"}, {"SPADE_ID": "SPADE_N_01058", "Similarity": 1.0, "Sequence": "ILGPVLSMVGSALGGLIKKI"}]}}}